Biological Seed Treatment Market to Showcase Continued Growth in the Coming Years

By -

The global biological seed treatment market is estimated to be valued at USD 0.9 billion in 2020 and is projected to reach USD 1.7 billion by 2025, recording a CAGR of 11.9%

Biological Seed Treatment Market

Biological Seed Treatment Market

(EMAILWIRE.COM, March 25, 2021 ) The report "Biological Seed Treatment Market by Type (Microbials and Botanicals), Crop (Corn, Wheat, Soybean, Cotton, Sunflower, and Vegetable Crops), Function (Seed Protection and Seed Enhancement), and Region - Global Forecast to 2025", is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market is driven by factors such as high demand for sustainable agriculture in the global market, lesser risks of exceeding pesticide MRLs, and insurance to seed investments.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

COVID-19 impact on Biological Seed Treatment market

The biological seed treatment market includes major Tier I and II suppliers like BASF SE (Germany), Bayer AG (Germany), Novozymes A/S (Denmark), Syngenta Group (Switzerland) and Corteva Agriscience (US). These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. As a result of the COVID-19 pandemic, there had been a supply chain disruption, due to which the agricultural sector had to face problems, such as labor unavailability, transportation barriers, restriction for market access, and the lack of inventories in some regions. Many manufacturers were facing issues due to the lack of raw material availability, which led to the reduction of seed treatment product manufacturing that includes biological seed treatment products. Post COVID-19, the agricultural activities have normalized, which has helped the companies to deliver products to the required places. Similar to the other biological agricultural product, seed treatment product also plays an important role, as it has been able to serve as an important solution for farmers across the globe.

By type, microbials segment is projected to dominate the seed treatment market during the forecast period.

The biological seed treatment market, by type, has been segmented into microbials, botanicals, and others (biofermentation products and natural polymers & derivatives). The microbials industry dominated the market in 2020, due to the increasing demand for microbial seed treatments, in field crops such as soybean and corn.

Many key companies, such as Bayer AG (Germany), Syngenta Group (Switzerland), and Corteva Agriscience (US), offer innovative biological seed treatment solutions for controlling seed and soil-borne diseases in a broad range of crops. This exponential growth in this North America region is attributed to government subsidies, increasing need to improve and protect food production, and rising awareness of biological seed treatment.

By function, seed protection segment is projected to be the fastest-growing segment in the seed treatment market during the forecast period.

On the basis of function, the biological seed treatment market has broadly been segmented into seed enhancement and seed protection. Biological seed treatments aimed at seed protection provide targeted control of certain pests and fungal diseases during the early seedling stage. Biological seed treatments are used on multiple crops to control a variety of pests. It ensures uniform stand establishment through defense against numerous soil-borne pathogens and insects.

North America is projected to be the fastest-growing market

The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirement and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to a higher adoption of these products.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162422288

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group(Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), Marrone Bio Innovation (US), Certis Europe (Netherlands), UPL Limited (India), Novozymes A/S (Denmark), IPL Biologicals (India), Rizobacter (Argentina), Bioworks, Inc (US), Advanced Biological Marketing (US), Kan Biosys (India), and Incotec (Netherlands).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more